<?xml version="1.0" encoding="UTF-8"?><template xmlns="openEHR/v1/Template" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><id>a4bd7cdd-80d9-4486-b003-dda34b3fbe0f</id><name>PHARM INV PEMBROLIZUMAB (MK-3475) IN NACL 0.9 Percent 50 ML BAG MK-2870-012 (TRIAL SUPPLY) [740241] Order</name><description><lifecycle_state>Initial</lifecycle_state><details><purpose/><use/><misuse/></details><other_details><item><key>MetaDataSet:Sample Set </key><value>Template metadata sample set </value></item><item><key>Acknowledgements</key><value/></item><item><key>Business Process Level</key><value/></item><item><key>Care setting</key><value/></item><item><key>Client group</key><value/></item><item><key>Clinical Record Element</key><value/></item><item><key>Copyright</key><value/></item><item><key>Issues</key><value/></item><item><key>Owner</key><value/></item><item><key>Sign off</key><value/></item><item><key>Speciality</key><value/></item><item><key>User roles</key><value/></item></other_details></description><annotations path="[openEHR-EHR-INSTRUCTION.service_request.v1]"><items><item><key>Technical.EPIC ID</key><value>&lt;p&gt;ERX740241&lt;/p&gt;</value></item><item><key>Catalogue Pattern.Synonyms</key><value>
						&lt;p&gt;
						INVESTIGATIONAL&lt;br&gt;
								RESEARCH&lt;br&gt;
								STUDY
						&lt;/p&gt;
					</value></item><item><key>Technical.ï»© Technical Traceability</key><value>{~AHSID~a4bd7cdd-80d9-4486-b003-dda34b3fbe0f~NAME~PHARM INV PEMBROLIZUMAB (MK-3475) IN NACL 0.9 Percent 50 ML BAG MK-2870-012 (TRIAL SUPPLY) [740241] Order}</value></item></items></annotations><definition xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" concept_name="Service request" max="1" name="INV pembrolizumab (MK-3475) in NaCl 0.9% 50 mL bag / MK-2870-012 (Trial supply)"/><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1"><digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest></integrity_checks></template>